These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2512464)

  • 21. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
    BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization.
    Pollack M; Prescott RK
    J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice.
    Miyazaki S; Matsumoto T; Tateda K; Ohno A; Yamaguchi K
    J Med Microbiol; 1995 Sep; 43(3):169-75. PubMed ID: 7650723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotoxins containing Pseudomonas exotoxin A: a short history.
    Pastan I
    Cancer Immunol Immunother; 2003 May; 52(5):338-41. PubMed ID: 12700949
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies.
    Rutault K; Coin D; Vacheron MJ; Guinand M; Wallach J; Michel G
    FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygenation activity of chicken blood phagocytes as measured by luminol- and lucigenin-dependent chemiluminescence.
    Desmidt M; Van Nerom A; Haesebrouck F; Ducatelle R; Ysebaert MT
    Vet Immunol Immunopathol; 1996 Oct; 53(3-4):303-11. PubMed ID: 8969050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients.
    Crowe KE; Bass JA; Young VM; Straus DC
    J Clin Microbiol; 1982 Jan; 15(1):115-22. PubMed ID: 6821202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host translational inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an immune response in Caenorhabditis elegans.
    McEwan DL; Kirienko NV; Ausubel FM
    Cell Host Microbe; 2012 Apr; 11(4):364-74. PubMed ID: 22520464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Pseudomonas aeruginosa exotoxin A on CD3-induced human T-cell activation.
    Michalkiewicz J; Stachowski J; Barth C; Patzer J; Dzierzanowska D; Runowski D; Madalinski K
    Immunol Lett; 1998 Apr; 61(2-3):79-88. PubMed ID: 9657258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of exotoxin A in pseudomonas disease and immunity.
    Pollack M
    Rev Infect Dis; 1983; 5 Suppl 5():S979-84. PubMed ID: 6419320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoenzyme method of determining Pseudomonas aeruginosa exotoxin A by using a conjugate of beta-lactamase with specific antibodies].
    Aleksandrova IA; Sazykin AIu; Aleksandrov AD; Moroz AF
    Antibiot Med Biotekhnol; 1987 Sep; 32(9):693-6. PubMed ID: 3124727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
    Homma JY; Tanimoto H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
    [No Abstract]   [Full Text] [Related]  

  • 33. Mice immunized with DNA encoding a modified Pseudomonas aeruginosa exotoxin A develop protective immunity against exotoxin intoxication.
    Shiau JW; Tang TK; Shih YL; Tai C; Sung YY; Huang JL; Yang HL
    Vaccine; 2000 Dec; 19(9-10):1106-12. PubMed ID: 11137245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A].
    Egizova SA; Deriabin PN; Karal'nik BV; Kanapina ASh; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):38-41. PubMed ID: 3149841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
    Homma JY; Tanimoto H
    Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
    [No Abstract]   [Full Text] [Related]  

  • 36. [Isolation of Pseudomonas aeruginosa exotoxin A by affinity chromatography using specific antibodies].
    Vovk VA; Uchakina NA
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Apr; (4):64-8. PubMed ID: 2500003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A.
    Klinger KW; Shuster CW
    Infect Immun; 1984 Mar; 43(3):912-9. PubMed ID: 6421741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A.
    Honda S; Ichimori Y; Iwasa S
    Cytotechnology; 1990 Jul; 4(1):59-68. PubMed ID: 1369279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)].
    Shinozaki T; Fujii R; Sanai Y; Homma JY
    Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.